West Pharmaceutical Services, Inc. (BMV:WST)

BMV:WST Ratios and Metrics

Market cap in millions MXN. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	May 21, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	293,765	494,319	440,454	339,868	712,272	416,758
Market Cap Growth	-31.09%	12.23%	29.60%	-52.28%	70.91%	98.65%
Enterprise Value	291,887	490,505	430,449	331,498	704,638	412,980
Last Close Price	4098.00	6396.72	6597.09	6715.26	9545.75	-
PE Ratio	30.76	48.15	43.91	29.74	52.50	60.50
PS Ratio	4.96	8.20	8.83	6.04	12.27	9.76
PB Ratio	5.36	8.84	9.04	6.49	14.88	11.29
P/TBV Ratio	5.60	9.25	9.45	6.81	15.78	12.23
P/FCF Ratio	46.83	85.83	62.86	39.65	105.09	70.26
P/OCF Ratio	21.63	36.31	33.55	24.07	59.49	44.33
EV/Sales Ratio	5.20	8.14	8.63	5.89	12.14	9.67
EV/EBITDA Ratio	18.62	31.43	30.19	19.22	38.58	39.03
EV/EBIT Ratio	24.65	39.66	36.05	22.25	44.72	49.11
EV/FCF Ratio	46.53	85.17	61.43	38.68	103.97	69.62
Debt / Equity Ratio	0.12	0.11	0.11	0.12	0.14	0.18
Debt / EBITDA Ratio	0.39	0.39	0.35	0.35	0.36	0.60
Debt / FCF Ratio	1.00	1.11	0.75	0.72	0.98	1.11
Asset Turnover	0.80	0.77	0.79	0.83	0.93	0.84
Inventory Turnover	4.63	4.67	4.28	4.41	4.73	4.95
Quick Ratio	1.85	1.93	2.07	2.73	2.13	1.99
Current Ratio	2.77	2.80	2.88	3.70	2.93	2.73
Return on Equity (ROE)	17.42%	17.71%	21.32%	23.34%	31.59%	20.20%
Return on Assets (ROA)	10.33%	9.93%	11.86%	13.78%	15.73%	10.29%
Return on Capital (ROIC)	12.48%	12.01%	14.25%	16.86%	19.82%	12.92%
Return on Capital Employed (ROCE)	19.30%	19.20%	22.40%	24.70%	28.30%	18.50%
Earnings Yield	3.25%	2.08%	2.28%	3.36%	1.91%	1.65%
FCF Yield	2.14%	1.17%	1.59%	2.52%	0.95%	1.42%
Dividend Yield	0.40%	0.26%	0.20%	0.21%	0.15%	-
Payout Ratio	12.76%	12.00%	9.61%	9.23%	7.72%	13.89%
Buyback Yield / Dilution	2.10%	2.13%	0.66%	0.66%	-0.66%	-0.53%
Total Shareholder Return	2.50%	2.39%	0.86%	0.87%	-0.51%	-0.53%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.